TD Cowen lowers Moderna (NASDAQ:MRNA) price target from $145 to $125

By / / Cowen, Moderna

TD Cowen analyst Tyler Van Buren downgrades Moderna (NASDAQ:MRNA) from Outperform to Market Perform and lowers the price target from $145 to $125.

Scroll to Top